Latest Form 144 filings
Officers, directors and other affiliates of a company file Form 144 when they place an order to sell restricted or control shares, if they plan to sell more than 5,000 shares or more than $50,000 worth within three months. It is a notice of a planned sale; officers and directors report the sale itself later on Form 4. 13D, 13G and Form 144 explained
Form 144 notices
Newest first. When a Form 144/A amends a notice, only the amendment is listed.
Filed in the last 365 days (US Eastern dates).
Form 144 filings on Livermore: Jan 4, 2023 to Oct 5, 2026.
Notices with a clearly misreported market value are left out of this list and its totals; they still appear, flagged, on the company's page. A value counts as misreported when the price per share it implies is far above the company's prices in Form 4 trades and 13F filings around the planned sale date.
- Notices
- 413
- Market value to sell
- $1.41B
- Sellers
- 117
- Companies
- 37
- Under 10b5-1 plans
- 220
| Company | Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|---|
| PBYIPuma Biotechnology, Inc. | Jan 7, 20264:24 PM ET | Nougues Maximo FOfficer | 6.41K | $37.7K | Jan 7, 2026 | Fidelity Brokerage Services LLC | SEC |
| AXSMAxsome Therapeutics, Inc. | Jan 6, 20264:58 PM ET | Herriot TabuteauOfficer | 29.4K | $5.06M | Jan 6, 202610b5-1 | Goldman Sachs & Co. LLC | SEC |
| ADPTAdaptive Biotechnologies Corp | Jan 6, 20264:57 PM ET | Harlan RobinsOfficer | 10.0K | $161.1K | Jan 6, 202610b5-1 | Goldman Sachs & Co. LLC | SEC |
| PBYIPuma Biotechnology, Inc. | Jan 6, 20264:53 PM ET | Nougues Maximo FOfficer | 4.54K | $26.5K | Jan 6, 2026 | Fidelity Brokerage Services LLC | SEC |
| PBYIPuma Biotechnology, Inc. | Jan 6, 20264:45 PM ET | Hunt Douglas MOfficer | 3.97K | $23.2K | Jan 6, 2026 | Fidelity Brokerage Services LLC | SEC |
| PBYIPuma Biotechnology, Inc. | Jan 6, 20264:44 PM ET | Auerbach Alan HOfficer · Director | 16.9K | $99.0K | Jan 6, 2026 | Fidelity Brokerage Services LLC | SEC |
| IOTSamsara Inc. | Jan 6, 20264:42 PM ET | Biswas SanjitOfficer · Director · 10% stockholder | 1.06M | $36.4M | Jan 6, 202610b5-1 | Charles Schwab & Co., Inc. | SEC |
| IOTSamsara Inc. | Jan 6, 20264:40 PM ET | Bicket JohnOfficer · Director · 10% stockholder | 1.06M | $36.4M | Jan 6, 202610b5-1 | Charles Schwab & Co., Inc. | SEC |
| PTCTPTC Therapeutics, Inc. | Jan 6, 20264:25 PM ET | Boulding Mark ElliottOfficer | 1.74K | $133.8K | Jan 6, 2026 | Fidelity Brokerage Services LLC | SEC |
| ADPTAdaptive Biotechnologies Corp | Jan 5, 20266:22 PM ET | Chad RobinsOfficer | 125.0K | $2.02M | Jan 5, 202610b5-1 | Goldman Sachs & Co. LLC | SEC |
| AXSMAxsome Therapeutics, Inc. | Jan 5, 20265:18 PM ET | Herriot TabuteauOfficer | 78.7K | $13.5M | Jan 5, 2026 | Goldman Sachs & Co. LLC | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Jan 5, 20264:01 PM ET | Patrick BurnettOfficer | 2.49K | $72.2K | Jan 5, 202610b5-1 | Merrill Lynch | SEC |
| PTCTPTC Therapeutics, Inc. | Jan 5, 20262:00 PM ET | Boulding Mark ElliottOfficer | 2.27K | $172.2K | Jan 5, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| IOTSamsara Inc. | Jan 2, 20264:33 PM ET | Dominic PhillipsOfficer | 54.0K | $1.91M | Jan 2, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| VIRVir Biotechnology, Inc. | Jan 2, 20264:29 PM ET | Vicki Lee SatoDirector | 66.0K | $398.0K | Jan 2, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Jan 2, 20264:00 PM ET | Howard WelgusDirector | 10.0K | $289.6K | Jan 2, 202610b5-1 | Merrill | SEC |
| TFPMTriple Flag Precious Metals Corp. | Dec 31, 20255:01 PM ET | Elliott Investment Management, L.P. (1)Shareholder | 2.77M | $92.7M | Dec 31, 2025 | Goldman Sachs & Co. LLC | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Dec 31, 20254:01 PM ET | Patrick BurnettOfficer | 1.70K | $49.6K | Dec 31, 2025 | Merrill Lynch | SEC |
| IOTSamsara Inc. | Dec 30, 20254:23 PM ET | Kirchhoff Benjamin LouisOfficer | 1.68K | $60.8K | Dec 30, 202510b5-1 | Charles Schwab & Co., Inc. | SEC |
| IOTSamsara Inc. | Dec 29, 20257:49 AM ET | Jonathan ChadwickDirector | 20.0K | $731.2K | Dec 26, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| LEGNLegend Biotech Corp | Dec 29, 20257:28 AM ET | Huang YingOfficer · Director | 64.3K | $1.45M | Dec 26, 202510b5-1 | Fidelity Brokerage Services LLC | SEC |
| LEGNLegend Biotech Corp | Dec 29, 20256:45 AM ET | Sanders Corazon (Corsee) D.Director | 969 | $22.1K | Dec 24, 202510b5-1 | Fidelity Brokerage Services LLC | SEC |
| LEGNLegend Biotech Corp | Dec 29, 20256:40 AM ET | Huang YingOfficer · Director | 61.5K | $1.41M | Dec 24, 2025 | Fidelity Brokerage Services LLC | SEC |
| IOTSamsara Inc. | Dec 22, 20254:23 PM ET | Adam EltoukhyOfficer | 14.1K | $537.1K | Dec 22, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| IOTSamsara Inc. | Dec 17, 20255:09 PM ET | Biswas SanjitOfficer · Director · 10% stockholder | 320.0K | $12.3M | Dec 17, 202510b5-1 | Charles Schwab & Co., Inc. | SEC |
| IOTSamsara Inc. | Dec 17, 20255:08 PM ET | Bicket JohnOfficer · Director · 10% stockholder | 340.0K | $13.1M | Dec 17, 202510b5-1 | Charles Schwab & Co., Inc. | SEC |
| GWREGuidewire Software, Inc. | Dec 16, 20257:15 PM ET | Jeffrey Elliott CooperChief Financial Officer | 2.87K | $551.6K | Dec 16, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| ADPTAdaptive Biotechnologies Corp | Dec 15, 20254:24 PM ET | Francis LoOfficer | 136.7K | $2.11M | Dec 15, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| ARTVArtiva Biotherapeutics, Inc. | Dec 15, 20254:18 PM ET | Fred AslanDirector · Officer | 12.7K | $42.1K | Dec 15, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Dec 15, 20254:07 PM ET | Patrick BurnettOfficer | 11.5K | $332.9K | Dec 15, 202510b5-1 | Merrill Lynch | SEC |
| IOTSamsara Inc. | Dec 15, 20254:03 PM ET | Phillips DominicOfficer | 48.1K | $1.96M | Dec 15, 2025 | Charles Schwab & Co., Inc. | SEC |
| MARMarriott International Inc | Dec 15, 20254:03 PM ET | Lee FelitiaOfficer | 528 | $162.6K | Dec 15, 2025 | Fidelity Brokerage Services LLC | SEC |
| IOTSamsara Inc. | Dec 15, 20254:03 PM ET | Eltoukhy AdamOfficer | 19.0K | $771.6K | Dec 15, 2025 | Charles Schwab & Co., Inc. | SEC |
| MARMarriott International Inc | Dec 15, 202511:37 AM ET | Lee FelitiaOfficer | 1.09K | $332.1K | Dec 15, 2025 | Fidelity Brokerage Services LLC | SEC |
| DGDollar General Corp | Dec 12, 20254:34 PM ET | Anita ElliottOfficer | 2.52K | $333.4K | Dec 12, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| IOTSamsara Inc. | Dec 10, 20254:41 PM ET | Phillips DominicOfficer | 8.23K | $366.0K | Dec 10, 2025 | Charles Schwab & Co., Inc. | SEC |
| IOTSamsara Inc. | Dec 10, 20254:40 PM ET | Kirchhoff Benjamin LouisOfficer | 1.61K | $71.5K | Dec 10, 2025 | Charles Schwab & Co., Inc. | SEC |
| IOTSamsara Inc. | Dec 10, 20254:39 PM ET | Eltoukhy AdamOfficer | 9.50K | $422.2K | Dec 10, 2025 | Charles Schwab & Co., Inc. | SEC |
| ADPTAdaptive Biotechnologies Corp | Dec 10, 20254:03 PM ET | Robert M HershbergDirector | 23.0K | $367.5K | Dec 10, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| FTHFaeth Therapeutics, Inc. | Dec 9, 202512:20 PM ET | Peyer JamesFormer director | 841 | $6.71K | Dec 9, 2025 | Fidelity Brokerage Services LLC | SEC |
| ADPTAdaptive Biotechnologies Corp | Dec 4, 20255:15 PM ET | Harlan RobinsOfficer | 10.0K | $174.6K | Dec 4, 202510b5-1 | Goldman Sachs & Co. LLC | SEC |
| AXSMAxsome Therapeutics, Inc. | Dec 4, 20255:11 PM ET | Herriot TabuteauOfficer | 10.6K | $1.56M | Dec 4, 202510b5-1 | Goldman Sachs & Co. LLC | SEC |
| KRYSKrystal Biotech, Inc. | Dec 4, 20254:40 PM ET | Krish KrishnanDirector · Officer · 10% stockholder | 25.0K | $5.44M | Dec 4, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| KRYSKrystal Biotech, Inc. | Dec 4, 20254:38 PM ET | Suma KrishnanDirector · Officer · 10% stockholder | 25.0K | $5.44M | Dec 4, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| ADPTAdaptive Biotechnologies Corp | Dec 4, 20254:38 PM ET | Sharon BenzenoOfficer | 12.6K | $215.9K | Dec 4, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| FTHFaeth Therapeutics, Inc. | Dec 4, 20254:18 PM ET | Cambrian BioPharma Inc10% stockholder | 5.84K | $50.9K | Dec 4, 2025 | Fidelity Brokerage Services LLC | SEC |
| FTHFaeth Therapeutics, Inc. | Dec 4, 20253:41 PM ET | Cambrian BioPharma Inc10% stockholder | 21.2K | $184.8K | Dec 4, 2025 | Fidelity Brokerage Services LLC | SEC |
| ADPTAdaptive Biotechnologies Corp | Dec 3, 20255:58 PM ET | Harlan RobinsOfficer | 27.2K | $466.1K | Dec 3, 202510b5-1 | Goldman Sachs & Co. LLC | SEC |
| AXSMAxsome Therapeutics, Inc. | Dec 3, 20255:58 PM ET | Herriot TabuteauOfficer | 20.2K | $2.98M | Dec 3, 202510b5-1 | Goldman Sachs & Co. LLC | SEC |
| AXSMAxsome Therapeutics, Inc. | Dec 2, 20255:14 PM ET | Herriot TabuteauOfficer | 49.3K | $7.00M | Dec 2, 202510b5-1 | Goldman Sachs & Co. LLC | SEC |